We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Sierra Oncology has announced that its experimental blood cancer treatment has reached all primary and key secondary endpoints in a phase 3 study, including maintaining platelet counts. Read More
Both studies are in line with real-world data released by the Centers for Disease Control and Prevention last week showing that a third dose of vaccine from Pfizer/BioNTech or Moderna slashed Omicron-related COVID-19 hospitalizations by 90 percent. Read More
Sanofi is partnering with Protas, a new UK-based nonprofit organization masterminded by Martin Landray, the leader of the UK’s lauded and highly successful RECOVERY trial, which evaluated multiple treatments for COVID-19. Read More
A Moderna or Pfizer/BioNTech COVID-19 booster dose was found to give highly effective protection against the Delta and Omicron variants, the Centers of Disease Control and Prevention (CDC) said Friday. Read More
The FDA has placed clinical holds on two drugs that use the transferrin receptor to gain access to their sites of action, raising concerns about the entire approach. Read More
As the Omicron variant rages, Peter Marks, the FDA’s top vaccine regulator, said that getting a booster dose earlier than six months after initial doses may be the best way to guard against the ubiquitous variant. Read More
In June 2021, the FDA approved Pfizer’s Prevnar 20 jab for preventing invasive disease and pneumonia from 20 different strains of streptococcus. Read More